Literature DB >> 2781495

[Changes in xanthine oxidase activity in patients with circulatory failure].

Z A Bakhtiiarov.   

Abstract

As many as 76 patients suffering from inactive rheumatic fever associated with different stages of heart failure were examined for uricemia, diurnal uricosuria, and xanthine oxidase activity in blood serum. It was established that in rheumatic fever, the activity of xanthine oxidase increased even at the early stages of heart failure. The presence in some of the patient of the enzyme activation combined with hyperuricosuria and normal content of uric acid in blood serum suggests "latent" hyperuricemia. In patients with severe heart decompensation, there was an appreciable activation of xanthine oxidase, which correlated, as a rule, with high hyperuricemia. Activation of xanthine oxidase in patients with rheumatic fever evidences hyperproduction of uric acid. It is advisable that in such cases the uricodepressive treatment may be indicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2781495

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  7 in total

1.  Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

Authors:  W Doehner; S D Anker
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study.

Authors:  Nihayet Bayraktar; Suleyman Kilic; Mehmet Refik Bayraktar; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 3.  Should a statin be prescribed to every patient with heart failure?

Authors:  Sofia G Tsouli; Evangelos N Liberopoulos; John A Goudevenos; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Heart Fail Rev       Date:  2007-08-12       Impact factor: 4.214

Review 4.  Acute and chronic endothelial dysfunction: implications for the development of heart failure.

Authors:  Axel Linke; Fabio Recchia; Xiaoping Zhang; Thomas H Hintze
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

5.  Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.

Authors:  Daniel Rob; Josef Marek; Gabriela Dostálová; Lubor Goláň; Aleš Linhart
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

6.  Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology.

Authors:  Ewa Romuk; Celina Wojciechowska; Wojciech Jacheć; Jolanta Nowak; Jacek Niedziela; Jolanta Malinowska-Borowska; Anna Głogowska-Gruszka; Ewa Birkner; Piotr Rozentryt
Journal:  Oxid Med Cell Longev       Date:  2019-09-17       Impact factor: 6.543

7.  Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses.

Authors:  Xiqiang Wang; Xiude Fan; Qihui Wu; Jing Liu; Linyan Wei; Dandan Yang; Xiang Bu; Xiaoxiang Liu; Aiqun Ma; Tomohiro Hayashi; Gongchang Guan; Yu Xiang; Shuang Shi; Junkui Wang; Jiansong Fang
Journal:  Front Cardiovasc Med       Date:  2022-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.